Rockwell Medical Technologies, Inc. - Financial and Strategic Analysis Review

Rockwell Medical Technologies, Inc. - Financial and Strategic Analysis Review

Summary

Global Markets Direct’s “Rockwell Medical Technologies, Inc. - Financial and Strategic Analysis Review” is an in-depth business, strategic and financial analysis of Rockwell Medical Technologies, Inc. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Rockwell Medical Technologies, Inc. (Rockwell) is engaged in the manufacture, sale and distribution of hemodialysis concentrate solutions and ancillary medical products. Rockwell’s products are used for performing dialysis on patients suffering from renal disease. Hemodialysis concentrates comprise of acidified dialysate concentrate, also known as acid concentrate and bicarbonate and is supplied principally to hemodialysis providers. The company also provides supplies utilized in the treatment of patients with End Stage Renal Disease (ESRD). It operates in the US, Latin America, Asia and Europe. It is headquartered in Michigan, the US.

Recent Developments

Oct 29, 2009: Rockwell Medical Ends SFP Phase IIb Clinical Study
Oct 06, 2009: Rockwell Appoints Jur Strobos To Its Scientific Advisory Board
Aug 10, 2009: Rockwell Reports Sales Of $13 Million In Q2 2009

Scope

• Provides key company information for business intelligence needs
• The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick “one-stop-shop” to understand the company.
• Enhance business/sales activities by understanding customers’ businesses better.
• Get detailed information and financial & strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitors’ weaknesses and target the market opportunities available to them.
• Compare your company’s financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.